Grail shares climb on FDA meeting date for Galleri test
Grail stock gained 15.8 percent in August, according to S&P Global Market Intelligence, but the advance was split cleanly in two. The first half of th
FDA
Every Fin-node story mentioning FDA — 1 story, newest first.
FDA · 1 story